These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8286930)
21. Modification of phosphorothioate oligonucleotides yields potent analogs with minimal toxicity for antisense experiments in the CNS. Peng Ho S; Livanov V; Zhang W; Li J; Lesher T Brain Res Mol Brain Res; 1998 Nov; 62(1):1-11. PubMed ID: 9795101 [TBL] [Abstract][Full Text] [Related]
23. Neutralization of tumor necrosis factor alpha (TNF alpha) action on cell proliferation in rat blastocysts by antisense oligodeoxyribonucleotides directed against TNF alpha p60 receptor. Pampfer S; Vanderheyden I; Vesela J; De Hertogh R Biol Reprod; 1995 Jun; 52(6):1316-26. PubMed ID: 7543296 [TBL] [Abstract][Full Text] [Related]
24. Binding of antisense phosphorothioate oligonucleotides to murine lymphocytes is lineage specific and inducible. Iversen PL; Crouse D; Zon G; Perry G Antisense Res Dev; 1992; 2(3):223-33. PubMed ID: 1490073 [TBL] [Abstract][Full Text] [Related]
25. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity. Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of troponin C production without affecting other muscle protein synthesis by the antisense oligodeoxynucleotide. Ojala J; Choudhury M; Bag J Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):31-8. PubMed ID: 9055036 [TBL] [Abstract][Full Text] [Related]
27. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms. Zelphati O; Imbach JL; Signoret N; Zon G; Rayner B; Leserman L Nucleic Acids Res; 1994 Oct; 22(20):4307-14. PubMed ID: 7524038 [TBL] [Abstract][Full Text] [Related]
28. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels. Smetsers TF; van de Locht LT; Pennings AH; Wessels HM; de Witte TM; Mensink EJ Leukemia; 1995 Jan; 9(1):118-30. PubMed ID: 7845006 [TBL] [Abstract][Full Text] [Related]
29. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization. Yaida Y; Nowak TS Regul Pept; 1995 Oct; 59(2):193-9. PubMed ID: 8584754 [TBL] [Abstract][Full Text] [Related]
30. Antisense phosphorothioate oligonucleotides direct both site-specific and nonspecific RNAse H cleavage of in vitro synthesized p120 mRNA. Weidner DA; Busch H Oncol Res; 1994; 6(6):237-42. PubMed ID: 7865899 [TBL] [Abstract][Full Text] [Related]
31. Involvement of a serine protease in tumour-necrosis-factor-mediated cytotoxicity. Suffys P; Beyaert R; Van Roy F; Fiers W Eur J Biochem; 1988 Dec; 178(1):257-65. PubMed ID: 3203692 [TBL] [Abstract][Full Text] [Related]
32. A cytotoxicity assay for tumor necrosis factor employing a multiwell fluorescence scanner. Trost LC; Lemasters JJ Anal Biochem; 1994 Jul; 220(1):149-53. PubMed ID: 7978238 [TBL] [Abstract][Full Text] [Related]
33. Effect of phosphorothioate modifications on the ability of GTn oligodeoxynucleotides to specifically recognize single-stranded DNA-binding proteins and to affect human cancer cellular growth. Morassutti C; Scaggiante B; Dapas B; Xodo L; Tell G; Quadrifoglio F Biochimie; 1999 Dec; 81(12):1115-22. PubMed ID: 10607406 [TBL] [Abstract][Full Text] [Related]
34. Specific inhibition of interleukin-10 production in murine macrophage-like cells by phosphorothioate antisense oligonucleotides. Arima H; Takahashi M; Aramaki Y; Sakamoto T; Tsuchiya S Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):319-27. PubMed ID: 9743469 [TBL] [Abstract][Full Text] [Related]
35. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. Chavany C; Connell Y; Neckers L Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902 [TBL] [Abstract][Full Text] [Related]
36. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. Kawasaki AM; Casper MD; Freier SM; Lesnik EA; Zounes MC; Cummins LL; Gonzalez C; Cook PD J Med Chem; 1993 Apr; 36(7):831-41. PubMed ID: 8464037 [TBL] [Abstract][Full Text] [Related]
37. Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides. Khaled Z; Benimetskaya L; Zeltser R; Khan T; Sharma HW; Narayanan R; Stein CA Nucleic Acids Res; 1996 Feb; 24(4):737-45. PubMed ID: 8604318 [TBL] [Abstract][Full Text] [Related]